Such an important topic!Sex-related eligibility criteria leading to exclusion of women from clinical trials. @hvanspall proposes pragmatic eligibility criteria facilitating enrolment of women &URM in RCTs
#CVCT2021 @CVCTForum @SantosGallegoMD @DrRaniKhatib @drdargaray
Brilliant slide by @hvanspall on strategies to increase diversity in clinical trials
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @Drroxmehran @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela
@FaiezZANNAD on geographic equity in CV clinical trials:increasing research capacity & trial enrolment in LMIC Case in point:MENA region
#CVCT2021 @CVCTForum @docbhardwaj @DjawidHashemi @DrRaniKhatib @hvanspall @DrRajivsankar @drdargaray @DVervoort94 @mirvatalasnag @Hragy
@FaiezZANNAD on geographic equity in CV clinical trials:increasing research capacity & trial enrolment in LMIC : What can be done??
#CVCT2021 @CVCTForum @docbhardwaj @DjawidHashemi @DrRaniKhatib @hvanspall @DrRajivsankar @drdargaray @DVervoort94 @SantosGallegoMD @ZainabDakhil2
Some real eye-opening data on the under-representation of women in clinical trials and trial leadership by @ErinMichos
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD
How to increase diverse population enrolment in RCT's?
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela @JavedButler1 @mirvatalasnag
@jjaimemiranda draws on Latam experiences of leading clinical trials in low income countries: lessons, challenges and opportunities #CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela @JavedButler1
More lessons from @jjaimemiranda on leading clinical trials in low income countries
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela @Hragy
@jjaimemiranda's most important lesson : PERSEVERE, PERSEVERE, PERSEVERE
@EldrinL speaks on harnessing the strength of community to enhance racial & ethnic diversity in CV clinical trials
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @DVervoort94 @SolovevaAnzhela
Solutions to increase diversity by @EldrinL
🎯Policy
🎯Investigator
🎯Patient
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @DVervoort94 @SolovevaAnzhela @rebeccaortega30
Harnessing the strength of the community to increase diversity in CV clinical trials @EldrinL #CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @DVervoort94 @SolovevaAnzhela @rebeccaortega30
@rebeccaortega30 on the role of catalyst organizations such as @WomenAs1 in closing diversity gaps in clinical trial leadership, esp given limitations of professional organizations despite moral imperative to prioritise DEI
#CVCT2021 @ShrillaB @RBP0612 @AllisonGHaysMD
@rebeccaortega30 announces that research training to be introduced as part of @WomenAs1 CLIMB program
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @SolovevaAnzhela @cristina_gavina
@FaiezZANNAD on the role of industry in increasing equity among clinical trial participants and trial investigators
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD
Strategies for industry sponsors by @FaiezZANNAD to promote diversity in clinical trials
Great publication by @hvanspall
#CVCT2021 @CVCTForum @docbhardwaj @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @drdargaray @DVervoort94 @WomenAs1 @drdargaray
An aptly diverse panel discussing the improvement of diversity in clinical trials
#CVCT2021 @FaiezZANNAD @hvanspall @jjaimemiranda @rebeccaortega30 @ErinMichos @EldrinL @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @DrRajivsankar @rachkataria @drdargaray
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.